A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TNBC

Search Conditions:
Search Keyword : TNBC
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TNBC
Appearance Frequency: 8826 time(s)
Long forms: 22

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
triple-negative breast cancer
(8648 times)
Neoplasms
(3860 times)
OS (640 times)
ER (441 times)
HER2 (409 times)
2008 Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
triple-negative BC
(131 times)
Neoplasms
(72 times)
BC (117 times)
OS (16 times)
HER2 (15 times)
2011 Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.
triple receptor-negative breast cancer
(15 times)
Neoplasms
(10 times)
OS (3 times)
RFS (3 times)
ER (2 times)
2009 Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
triple-negative subtype of breast cancer
(9 times)
Neoplasms
(3 times)
CAFs (1 time)
CAI (1 time)
CSC (1 time)
2016 TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
triple-negative (PR-, ER-, HER-2-) breast cancer
(4 times)
Medicine
(1 time)
ASMT (2 times)
PCTs (2 times)
TPBC (2 times)
2011 Vascular characterisation of triple negative breast carcinomas using dynamic MRI.
TNBC-TICs
(2 times)
Neoplasms
(1 time)
TPBC (2 times)
ER (1 time)
HER2 (1 time)
2012 A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.
TNBCtype
(2 times)
Medicine
(1 time)
FF (1 time)
FFPE (1 time)
IM (1 time)
2016 Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
third cancer of non-breast origin
(1 time)
Neoplasms
(1 time)
BBC (1 time)
CI (1 time)
HR (1 time)
2012 Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.
TN breast cancer
(1 time)
Veterinary Medicine
(1 time)
CK (1 time)
CMCs (1 time)
PR (1 time)
2021 Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.
10  TNBC MDA-MB-231 cell line and in vivo in an M-Wnt tumour-bearing
(1 time)
Chemistry
(1 time)
DOX (1 time)
PEG (1 time)
TAMs (1 time)
2023 Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
11  TNBC.Abbreviations:Triple-negative breast cancer
(1 time)
Drug Therapy
(1 time)
ADCs (1 time)
BCs (1 time)
BL1 (1 time)
2022 Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.
12  TNBC/DDP
(1 time)
Neoplasms
(1 time)
USP22 (1 time)
2022 USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
13  Trigeminal nerve balloon compression
(1 time)
Neurosurgery
(1 time)
--- 2022 Trigeminal Neuralgia-Step-by-Step DYNA-Computed Tomography-Assisted Balloon Compression Rhizotomy.
14  Triple Negative BC form
(1 time)
Neoplasms
(1 time)
BC (1 time)
2021 Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.
15  triple negative group of human breast carcinoma
(1 time)
Neoplasms
(1 time)
AA (1 time)
WI (1 time)
2012 Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.
16  Triple Negative subset of Breast Cancer
(1 time)
Medicine
(1 time)
RD (1 time)
WP (1 time)
2013 Differential activation of Wnt-beta-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
17  triple-negative (estrogen receptor, progesterone receptor, and HER-2/neu) breast cancer
(1 time)
Neoplasms
(1 time)
miRNAs (1 time)
2014 Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer.
18  triple-negative BC subtype
(1 time)
Cell Biology
(1 time)
BC (1 time)
BLBC (1 time)
EMT (1 time)
2021 Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
19  triple-negative breast carcinoma cell line MDA-MB-231
(1 time)
Cell Biology
(1 time)
TPBC (1 time)
2022 Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway.
20  triple-negative breast carcinomas of no special type
(1 time)
Cell Biology
(1 time)
HIF-1alpha (1 time)
LVD (1 time)
MVD (1 time)
2011 Angiogenesis in triple-negative adenoid cystic carcinomas of the breast.
21  triple-negative breast malignancies
(1 time)
Pathologic Processes
(1 time)
IBC (1 time)
2022 Revisiting Metaplastic Carcinoma of Breast: An Emphasis on the Clinico-pathological and Immunohistochemical Variables Analyzed at a Tertiary Cancer Centre in South India.
22  type breast cancer
(1 time)
Clinical Laboratory Techniques
(1 time)
--- 2011 Establishment of a triple-negative type human breast cancer cell line that selectively metastasizes to the lung after orthotropic implantation.